Featured Research

from universities, journals, and other organizations

Drug Therapy For Premature Infants Destroys Brain Cells In Mice

Date:
November 25, 2008
Source:
Washington University School of Medicine
Summary:
A class of drugs that are used in premature infants to treat chronic lung damage can cause damage in the brain. New research suggests the drugs may cause cognitive and motor-control problems even when they are given before birth.

A class of drugs that are used in premature infants to treat chronic lung damage can cause damage in the brain. New research at Washington University School of Medicine in St. Louis suggests the drugs may cause cognitive and motor-control problems even when they are given before birth.

The researchers have identified the cells damaged by the drugs, called glucocorticoids, as well as the time window during which brain injury can occur. They say it may be possible to avoid damage to brain cells and still aid the development of premature lungs if synthetic forms of the drugs can be replaced with hormones made naturally in the body.

The researchers reported their findings November 16 at Neuroscience 2008, the annual meeting of the Society for Neuroscience.

Studying the effects of the drugs in mice, the investigators found that the synthetic glucocorticoids dexamethasone and betamethasone, commonly prescribed to spur the development of premature lungs, cause damage in the brain's cerebellum, the structure that controls movement, as well as other functions.

Brain cells in the mice died following glucocorticoid treatment when the drugs were given between four and 10 days after birth. The corresponding window in human infants would be approximately 20 weeks of gestation to six weeks following birth. That's also the time span in which these drugs are given to pregnant women at risk for preterm birth or to prematurely born infants who are having problems breathing.

"The cells that are damaged are called neural progenitor cells, which are responsible for producing new neurons," says first author Kevin K. Noguchi, Ph.D., a scientist in the Department of Psychiatry. "So you can imagine that if you kill the cells responsible for producing new neurons, you can cause severe neurodevelopmental deficits."

That's exactly what the researchers found when they studied adolescent mice that had been treated with glucocorticoids during infancy. A single exposure to glucocorticoid drugs permanently decreased the number of neurons in the cerebellum of the mouse brain.

In the past, the steroid drugs were given to low-birthweight infants after they were born, but studies determined that exposure to the drugs following birth could lead to cognitive problems and neuromotor deficits, particularly difficulty with balance and coordination. In 2002, the American Academy of Pediatrics recommended post-natal glucocorticoid use be stopped unless used in clinical trials, but the drugs still are given frequently to mothers at risk for preterm birth.

"The cerebellum connects to other brain structures, so when granule cells in the cerebellum are lost, you also have detrimental effects on cognitive function in non-motor regions of the brain," says senior investigator Nuri B. Farber, M.D., associate professor of psychiatry. "Other researchers have found I.Q. declines in children who have received these drugs early in life, and our findings may help explain why."

But both Farber and Noguchi say therapy with these drugs may be essential for some children with immature lungs as a lifesaving measure. They believe, however, that it may be possible in the future to use different drugs to help the lungs mature without damaging brain cells.

"We're looking at differences between glucocorticoids that are made naturally in the body and hormones that are manufactured," says Noguchi. "The brain has some natural defenses against exposure to endogenous glucocorticoids but not the synthetic ones. So it may be possible to administer some of those natural hormones, which can help the lungs mature without putting the brain at risk."

It also may be possible to develop other drugs that would assist with lung development without killing cells in the cerebellum. But as they study those possibilities, the investigators say they want parents to know that the observed toxic effects of steroid drugs are not a problem for adults and older children. They estimate that by about three months of age, human infants no longer are at high risk for this damage.

"The toxic effects decline when the cerebellum finally finishes its development," Farber says. "These drugs are used for many different purposes, so there are other reasons why a baby might get prednisone or dexamethasone or another glucocorticoid, but our research in mice suggests once a human infant is a few months old, these drugs have fairly innocuous effects in the brain."

Reference: Noguchi, KK, Smith DJ, Swiney BS, Farber NB. Acute exposure to multiple corticosteroids can induce selective apoptotic cell death in the neural progenitor cells of the developing cerebellum of neonatal mice. Abstract, presented Nov. 17, 2008 at Neuroscience 2008.

This research was supported by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by Washington University School of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School of Medicine. "Drug Therapy For Premature Infants Destroys Brain Cells In Mice." ScienceDaily. ScienceDaily, 25 November 2008. <www.sciencedaily.com/releases/2008/11/081117121227.htm>.
Washington University School of Medicine. (2008, November 25). Drug Therapy For Premature Infants Destroys Brain Cells In Mice. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/11/081117121227.htm
Washington University School of Medicine. "Drug Therapy For Premature Infants Destroys Brain Cells In Mice." ScienceDaily. www.sciencedaily.com/releases/2008/11/081117121227.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins